Antibody Production Antibody Production Market

According to the report published by Zion Market Research, global demand for the Antibody Production market was valued at approximately USD 10.86 Billion in 2019 and is expected to generate revenue of around USD 24.00 Billion by end of 2026, growing at a CAGR of around 12.01% between 2020 and 2026.

Global Antibody Production Market: Overview

The immune system produces antibodies secreted in the blood, which are protein molecules produced in response to the antigens, foreign particles such as viruses, fungi, and bacteria. The antibodies function by neutralizing or inhibiting the antigen activity. The production of an antibody is dependent on the humoral response of the immune system to the introduction of foreign particles into the body. Polyclonal antibodies and monoclonal antibodies are the basic types of antibodies produced by the immune system. Polyclonal antibodies are produced from many dissimilar immune cells whereas monoclonal antibodies are produced by similar immune cells which are duplicates of a distinctive progenitor cell. The antibody production market consists of products essential for various steps of processing of antibodies, such as downstream processing, filtration, and upstream processing.

Global Antibody Production Market: Growth Factors

The major factors contributing to the growth of the antibody production market are the increasing need for protein curatives and the rising widespread presence of infectious disease. The other factors propelling the growth of the market are the patent cessation of successful monoclonal antibodies, raised R&D disbursement of biotechnology and pharmaceutical companies, rising acceptance of targeted immunotherapy, and therapeutic antibodies by governing authorities.

Global Antibody Production Market: Segmentation

The antibody production market may be classified based on end-users and process. The end-users segment of the global market can be further divided into research institutes, diagnostic laboratories, and biotechnology and pharmaceutical companies. The biotechnology and pharmaceutical companies segment is anticipated to grow the most owing to the huge digit of drug development processes to meet the decreased industry timelines, attracting the companies to invest in the developmental and research activities. The process segment of the market may be divided into filtration, upstream processing, and downstream processing. The filtration segment of the market can be further categorized as filtration consumables and accessories and filtration systems. The upstream segment of the global antibody production market can be diversified into consumables and bioreactors. The consumables segment is sub-segmented as buffers & reagents and the media and bioreactors segment is sub-segmented as single-use bioreactors and large-scale bioreactors. The downstream segment can be categorized into chromatography resins and chromatography systems. The need for advanced and sensitive tools is expected to boost the growth of the downstream processing segment.

The antibody production market can also be segmented on the basis of application and type. The application segment of the market is further classified into cardiology, rheumatology, hematology/oncology, gastroenterology, transplantation, and infection. The type segment of the antibody production market can be categorized into polyclonal antibodies and monoclonal antibodies. The monoclonal antibody segment is further sub-segmented into humanized, murine, and chimeric.

 Region-wise, the global market is segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Global Antibody Production Market: Regional Analysis

North America is anticipated to be the rapidly growing region in the antibody production market due to government expenditure, increasing cancer incidence, and the requirement for quality cancer therapy. The Asia-Pacific region is also expected to boost in the market owing to the rising private sector and government expenditure, increasing infrastructural advancements, and government support.

Global Antibody Production Market: Competitive Players

The major players in the antibody production market are Sigma-Aldrich Corporation, GE Healthcare, Thermo Fisher Scientific, Inc., INTEGRA Biosciences AG, Cellab GmbH, and Eppendorf AG. The other prominent players in the market include Sartorius AG, Pall Corporation, Merck KGaA, and FiberCell Systems Inc.

Antibody Production Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa